S&P 500 Index (SP500)
Goldman Sachs listed its best free cash flow ideas, including Biogen (BIIB), Merck & Co. (MRK), and Regeneron Pharma (REGN).
These are stocks that offer expanding free cash flow margins through 2026 and attractive free cash flow yields through 2026.